Literature DB >> 23306850

Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer.

Seiji Ohigashi1, Kazuki Sudo, Daiki Kobayashi, Osamu Takahashi, Takuya Takahashi, Takashi Asahara, Koji Nomoto, Hisashi Onodera.   

Abstract

BACKGROUND: New molecular biology-based methods of bacterial identification are expected to help elucidate the relationship between colorectal cancer (CRC) and intestinal microbiota. Although there is increasing evidence revealing the potential role of microbiota in CRC, it remains unclear whether microbial dysbiosis is the cause or the result of CRC onset. AIM: We investigated the changes of intestinal environments in CRC or adenoma.
METHODS: We analyzed 13 groups of microbiota, 8 types of organic acids, and pH in feces obtained from the following 3 groups: individuals with CRC, adenoma, and non-adenoma. Ninety-three patients with CRC and 49 healthy individuals (22 with adenoma and 27 without adenoma) were enrolled.
RESULTS: The counts of total bacteria (10.3 ± 0.7 vs. 10.8 ± 0.3 log10 cells/g of feces; p < 0.001), 5 groups of obligate anaerobe, and 2 groups of facultative anaerobes were significantly lower in the CRC group than in the healthy individuals. While the concentrations of short chain fatty acids (SCFAs) were significantly decreased in the CRC group, the pH was increased in the CRC group (7.4 ± 0.8 vs. 6.9 ± 0.6; p < 0.001). Comparison among the CRC, adenoma, and non-adenoma groups revealed that fecal SCFAs and pH in the adenoma group were intermediate to the CRC group and the non-adenoma group. Within the CRC group, no differences in microbiota or organic acids were observed among Dukes stages.
CONCLUSIONS: CRC patients showed significant differences in the intestinal environment, including alterations of microbiota, decreased SCFAs, and elevated pH. These changes are not a result of CRC progression but are involved in CRC onset.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306850     DOI: 10.1007/s10620-012-2526-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

Review 1.  [Development of quantitative PCR detection method with 16S rRNA gene-targeted genus- and species-specific primers for the analysis of human intestinal microflora and its application].

Authors:  Takahiro Matsuki
Journal:  Nihon Saikingaku Zasshi       Date:  2007-05

2.  Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study.

Authors:  Susanne Mueller; Katiana Saunier; Christiana Hanisch; Elisabeth Norin; Livia Alm; Tore Midtvedt; Alberto Cresci; Stefania Silvi; Carla Orpianesi; Maria Cristina Verdenelli; Thomas Clavel; Corinna Koebnick; Hans-Joachim Franz Zunft; Joël Doré; Michael Blaut
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

3.  Production of cytokines by monocytes, epithelial and endothelial cells activated by Streptococcus bovis.

Authors:  S Ellmerich; N Djouder; M Schöller; J P Klein
Journal:  Cytokine       Date:  2000-01       Impact factor: 3.861

4.  Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers.

Authors:  T Matsuki; K Watanabe; R Tanaka; M Fukuda; H Oyaizu
Journal:  Appl Environ Microbiol       Date:  1999-10       Impact factor: 4.792

5.  Possibility of preventing colorectal carcinogenesis with probiotics.

Authors:  Tadashi Ohara; Keiichi Yoshino; Masaki Kitajima
Journal:  Hepatogastroenterology       Date:  2010 Nov-Dec

6.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

7.  Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces.

Authors:  Takahiro Matsuki; Koichi Watanabe; Junji Fujimoto; Toshihiko Takada; Ryuichiro Tanaka
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

8.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood.

Authors:  J H Cummings; E W Pomare; W J Branch; C P Naylor; G T Macfarlane
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

Review 9.  Review article: nutrition, obesity and colorectal cancer.

Authors:  I T Johnson; E K Lund
Journal:  Aliment Pharmacol Ther       Date:  2007-07-15       Impact factor: 8.171

10.  A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients.

Authors:  Luca Gianotti; Lorenzo Morelli; Francesca Galbiati; Simona Rocchetti; Sara Coppola; Aldo Beneduce; Cristina Gilardini; Daniela Zonenschain; Angelo Nespoli; Marco Braga
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

View more
  57 in total

Review 1.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

2.  Significant changes in the intestinal environment after surgery in patients with colorectal cancer.

Authors:  Seiji Ohigashi; Kazuki Sudo; Daiki Kobayashi; Takuya Takahashi; Koji Nomoto; Hisashi Onodera
Journal:  J Gastrointest Surg       Date:  2013-06-27       Impact factor: 3.452

Review 3.  Gut microbiome and colorectal adenomas.

Authors:  Santosh Dulal; Temitope O Keku
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

4.  Yogurt consumption and colorectal polyps.

Authors:  Samara B Rifkin; Francis M Giardiello; Xiangzhu Zhu; Linda M Hylind; Reid M Ness; Julia L Drewes; Harvey J Murff; Emma H Spence; Walter E Smalley; Joell J Gills; Gerard E Mullin; David Kafonek; Louis La Luna; Wei Zheng; Cynthia L Sears; Martha J Shrubsole
Journal:  Br J Nutr       Date:  2020-02-20       Impact factor: 3.718

Review 5.  The gastrointestinal microbiota and colorectal cancer.

Authors:  Temitope O Keku; Santosh Dulal; April Deveaux; Biljana Jovov; Xuesong Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-24       Impact factor: 4.052

Review 6.  Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.

Authors:  Larissa S Celiberto; Franziska A Graef; Genelle R Healey; Else S Bosman; Kevan Jacobson; Laura M Sly; Bruce A Vallance
Journal:  Immunology       Date:  2018-05-16       Impact factor: 7.397

7.  Effects of Lactobacillus salivarius Ren on cancer prevention and intestinal microbiota in 1, 2-dimethylhydrazine-induced rat model.

Authors:  Ming Zhang; Xing Fan; Bing Fang; Chengzhen Zhu; Jun Zhu; Fazheng Ren
Journal:  J Microbiol       Date:  2015-05-30       Impact factor: 3.422

8.  Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.

Authors:  Efrat L Amitay; Agne Krilaviciute; Hermann Brenner
Journal:  Gut Microbes       Date:  2018-05-15

9.  Novel Method for Screening Colorectal Neoplasm.

Authors:  Hisashi Onodera
Journal:  EBioMedicine       Date:  2015-05-22       Impact factor: 8.143

10.  Fecal microbes, short chain fatty acids, and colorectal cancer across racial/ethnic groups.

Authors:  Christina M Hester; Venkatakrishna R Jala; Morgan Gi Langille; Shahid Umar; K Allen Greiner; Bodduluri Haribabu
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.